Colon cancer blood test offers new screening option
Time:2024-05-22 10:59:23 Source:opinionsViews(143)
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Previous:Clark signs deal with Wilson Sporting Goods for signature line
Next:Vikings seek new deal with Justin Jefferson; star WR absent so far from workouts, AP source says
You may also like
- Vikings seek new deal with Justin Jefferson; star WR absent so far from workouts, AP source says
- Amid GOP focus on elections, Georgia Republicans remove officer found to have voted illegally
- Love Is Blind stars Zack and Bliss welcome their first child together
- Brazil floods: Forecast to worsen in south
- Congo names third American in a foiled coup plot as mourners gather in Utah to remember plot leader
- Why a judge put Beach Boys' Brian Wilson under conservatorship
- Biden highlights a coming showdown with GOP over 2017 tax cuts
- Nadal overpowered by Hurkacz at Italian Open in his 1st meeting with a top
- Guardians ruin Francisco Lindor's Cleveland homecoming, trip Mets 3